calendar
8,524 catalysts · 6,181 phase readout · 2,337 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,524 catalysts · 6,181 phase readout · 2,337 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 8.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.03, 9.01
Items: 1.01, 2.02, 3.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02, 8.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma
Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection
Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection
Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder